These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21723058)

  • 21. [A case of hemolytic uremic syndrome caused by verotoxin producing enteropathogenic Escherichia coli (O157:H7) with prolonged cerebrovascular dysfunction].
    Yaginuma M; Sazaki N
    Rinsho Shinkeigaku; 2000 Mar; 40(3):237-42. PubMed ID: 10885334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome.
    Brigotti M; Tazzari PL; Ravanelli E; Carnicelli D; Rocchi L; Arfilli V; Scavia G; Minelli F; Ricci F; Pagliaro P; Ferretti AV; Pecoraro C; Paglialonga F; Edefonti A; Procaccino MA; Tozzi AE; Caprioli A
    Pediatr Infect Dis J; 2011 Jun; 30(6):486-90. PubMed ID: 21164386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study.
    Gerber A; Karch H; Allerberger F; Verweyen HM; Zimmerhackl LB
    J Infect Dis; 2002 Aug; 186(4):493-500. PubMed ID: 12195376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prothrombotic coagulation abnormalities preceding the hemolytic-uremic syndrome.
    Chandler WL; Jelacic S; Boster DR; Ciol MA; Williams GD; Watkins SL; Igarashi T; Tarr PI
    N Engl J Med; 2002 Jan; 346(1):23-32. PubMed ID: 11777999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cluster of Escherichia coli O157:H7 infections with the hemolytic-uremic syndrome and death in California. A mandate for improved surveillance.
    Shefer AM; Koo D; Werner SB; Mintz ED; Baron R; Wells JG; Barrett TJ; Ginsberg M; Bryant R; Abbott S; Griffin PM
    West J Med; 1996; 165(1-2):15-9. PubMed ID: 8855679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult hemolytic-uremic syndrome associated with urosepsis due to Shigatoxin-producing Escherichia coli O138:H-.
    Nguyen QV; Hochstrasser L; Chuard C; Hächler H; Regamey C; Descombes E
    Ren Fail; 2007; 29(6):747-50. PubMed ID: 17763172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemolytic uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157:H7 and other shiga toxin-producing E. coli.
    Mahon BE; Griffin PM; Mead PS; Tauxe RV
    Emerg Infect Dis; 1997; 3(3):409-12. PubMed ID: 9284395
    [No Abstract]   [Full Text] [Related]  

  • 28. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota.
    Martin DL; MacDonald KL; White KE; Soler JT; Osterholm MT
    N Engl J Med; 1990 Oct; 323(17):1161-7. PubMed ID: 2215593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 17-1997. A 67-year-old woman with vomiting, bloody diarrhea, and azotemia.
    N Engl J Med; 1997 May; 336(22):1587-94. PubMed ID: 9164816
    [No Abstract]   [Full Text] [Related]  

  • 30. Pediatric posterior reversible leukoencephalopathy syndrome and NSAID-induced acute tubular interstitial nephritis.
    Yokobori S; Yokota H; Yamamoto Y
    Pediatr Neurol; 2006 Mar; 34(3):245-7. PubMed ID: 16504799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli.
    Johnson KE; Thorpe CM; Sears CL
    Clin Infect Dis; 2006 Dec; 43(12):1587-95. PubMed ID: 17109294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemolytic uremic syndrome caused by enterohaemorrhagic Escherichia coli].
    Ibarra C; Goldstein J; Silberstein C; Zotta E; Belardo M; Repetto HA
    Arch Argent Pediatr; 2008 Oct; 106(5):435-42. PubMed ID: 19030644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Enterohemorrhagic Escherichia coli--infection and a hemolytic uremic syndrome].
    Helminen M; Wisakanto KL; Raisio M; Baer M
    Duodecim; 1998; 114(3):229-32. PubMed ID: 10895492
    [No Abstract]   [Full Text] [Related]  

  • 34. Posterior reversible encephalopathy syndrome as a revealing manifestation of Guillain-Barré syndrome.
    Etxeberria A; Lonneville S; Rutgers MP; Gille M
    Rev Neurol (Paris); 2012 Mar; 168(3):283-6. PubMed ID: 22318132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic susceptibility contrast enhanced MRI in reversible posterior leukoencephalopathy syndrome associated with haemolytic uraemic syndrome.
    Taylor MB; Jackson A; Weller JM
    Br J Radiol; 2000 Apr; 73(868):438-42. PubMed ID: 10844872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversible posterior leukoencephalopathy syndrome: a retrospective study in King Chulalongkorn Memorial Hospital.
    Tungkasaereerak C; Phanthumchinda K
    J Med Assoc Thai; 2008 Mar; 91(3):427-32. PubMed ID: 18575300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two cases of human urinary tract infection complicated by hemolytic uremic syndrome caused by verotoxin-producing Escherichia coli.
    Scheutz F; Olesen B; Nørgaard A
    Clin Infect Dis; 2000 Sep; 31(3):815-6. PubMed ID: 11017837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurologic manifestations of E coli infection-induced hemolytic-uremic syndrome in adults.
    Weissenborn K; Donnerstag F; Kielstein JT; Heeren M; Worthmann H; Hecker H; Schmitt R; Schiffer M; Pasedag T; Schuppner R; Tryc AB; Raab P; Hartmann H; Ding XQ; Hafer C; Menne J; Schmidt BM; Bültmann E; Haller H; Dengler R; Lanfermann H; Giesemann AM
    Neurology; 2012 Oct; 79(14):1466-73. PubMed ID: 22993286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversible posterior leukoencephalopathy syndrome after cervical transforaminal epidural steroid injection presenting as transient blindness.
    Kim W; Kim JS; Lim SC; Kim YI; Moon DE
    Anesth Analg; 2011 Apr; 112(4):967-70. PubMed ID: 21385981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posterior reversible encephalopathy syndrome in acute intermittent porphyria.
    Zhao B; Wei Q; Wang Y; Chen Y; Shang H
    Pediatr Neurol; 2014 Sep; 51(3):457-60. PubMed ID: 25035140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.